Rapport Therapeutics, Inc.(RAPP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RAPP Rapport Therapeutics, Inc.

盘前交易 07-11 05:31:39 EDT

15.38

+1.37

+9.78%

最高15.70	最低14.01	成交量26.11万
今开14.04	昨收14.01	日振幅12.06%
总市值5.61亿	流通市值2.30亿	总股本3,650万
成交额385.51万	换手率1.75%	流通股本1,494万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RAPP","market":"US","secType":"STK","nameCN":"Rapport Therapeutics, Inc.","latestPrice":15.38,"timestamp":1752177600000,"preClose":14.01,"halted":0,"volume":261132,"delay":0,"floatShares":14942743,"shares":36497677,"eps":-2.744216,"marketStatus":"盘前交易","change":1.37,"latestTime":"07-11 05:31:39 EDT","open":14.04,"high":15.7,"low":14.01,"amount":3855108.167316,"amplitude":0.120628,"askPrice":17.8,"askSize":100,"bidPrice":12.96,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.744216,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752240600000},"marketStatusCode":1,"adr":0,"listingDate":1717732800000,"exchange":"NASDAQ","adjPreClose":15.38,"postHourTrading":{"tag":"盘后","latestPrice":16,"preClose":15.38,"latestTime":"18:39 EDT","volume":2737,"amount":43493.74,"timestamp":1752187199412},"volumeRatio":1.6042492947788736,"impliedVol":0.3476,"impliedVolPercentile":0.1923},"requestUrl":"/m/hq/s/RAPP","defaultTab":"news","newsList":[{"id":"2539016296","title":"【纳斯达克生物科技指数收涨超2%】 成分股Oric Pharma收涨33.50%，Erasca涨32.73%，Tango Therapeutics涨20.10%表现第三。莱斯康制药则收跌5.66%跌幅第三大，Rapport Therapeutics跌10.46%，Intellia Therapeutics也跌22.88%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2539016296","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539016296?lang=zh_cn&edition=full","pubTime":"2025-05-30 04:53","pubTimestamp":1748551986,"startTime":"0","endTime":"0","summary":"成分股Oric Pharma收涨33.50%，Erasca涨32.73%，Tango Therapeutics涨20.10%表现第三。莱斯康制药则收跌5.66%跌幅第三大，Rapport Therapeutics跌10.46%，Intellia Therapeutics也跌22.88%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/30045350753450.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["MNQmain","LXRX","PSQ","NVIW.SI","LENZ","USAW.SI","USJW.SI","TSYW.SI","BK4007","SQQQ","ARTL","RAPP","BK4539",".IXIC","BK1147","NQmain","159632","ERAS","QID","159837","03086","BK4139","QLD","TQQQ"],"gpt_icon":0},{"id":"2537942719","title":"Rapport Therapeutics, Inc.盘中异动 早盘股价大涨5.18%报10.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537942719","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537942719?lang=zh_cn&edition=full","pubTime":"2025-05-22 21:57","pubTimestamp":1747922267,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日21时57分，Rapport Therapeutics, Inc.股票出现波动，股价大幅上涨5.18%。截至发稿，该股报10.56美元/股，成交量1.7325万股，换手率0.05%，振幅12.55%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052221574894ff44fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052221574894ff44fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4139","BK4007","RAPP"],"gpt_icon":0},{"id":"2537936723","title":"Rapport Therapeutics, Inc.盘中异动 快速拉升9.59%报11.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537936723","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537936723?lang=zh_cn&edition=full","pubTime":"2025-05-21 21:39","pubTimestamp":1747834789,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日21时39分，Rapport Therapeutics, Inc.股票出现异动，股价急速拉升9.59%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521213949a6e78623&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521213949a6e78623&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","BK4007","RAPP","LENZ"],"gpt_icon":0},{"id":"2536758475","title":"Rapport Therapeutics, Inc.2025财年第一财季实现净利润-24.06百万美元，同比减少6.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536758475","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536758475?lang=zh_cn&edition=full","pubTime":"2025-05-18 00:00","pubTimestamp":1747497627,"startTime":"0","endTime":"0","summary":"5月18日，Rapport Therapeutics, Inc.公布财报，公告显示公司2025财年第一财季净利润为-24.06百万美元，同比减少6.13%；其中营业收入为0.00美元，每股基本收益为-0.68美元。从资产负债表来看，Rapport Therapeutics, Inc.总负债16.22百万美元，其中短期债务1.01百万美元，资产负债比为0.19，流动比率为0.32。机构评级：截至2025年5月18日，当前有4家机构对Rapport Therapeutics, Inc.目标价做出预测，其中目标均价为35.00美元，其中最低目标价为28.00美元，最高目标价为42.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000148a6e2d816&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000148a6e2d816&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPP","LENZ"],"gpt_icon":0},{"id":"2536341025","title":"Rapport Therapeutics, Inc.盘中异动 下午盘急速拉升5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536341025","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536341025?lang=zh_cn&edition=full","pubTime":"2025-05-17 02:30","pubTimestamp":1747420243,"startTime":"0","endTime":"0","summary":"北京时间2025年05月17日02时30分，Rapport Therapeutics, Inc.股票出现波动，股价大幅上涨5.48%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Affimed N.V.、Inozyme Pharma, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Affimed N.V.、Polyrizon Ltd.、Nucana Plc较为活跃，换手率分别为5229.16%、3626.10%、1686.07%，振幅较大的相关个股有Affimed N.V.、Onconetix, Inc.、Vor Biopharma Inc.，振幅分别为466.98%、66.89%、66.82%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517023043a48136da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517023043a48136da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","BK4539","LENZ","RAPP"],"gpt_icon":0},{"id":"2535407473","title":"Rapport Therapeutics, Inc.盘中异动 大幅下跌5.46%报9.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535407473","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535407473?lang=zh_cn&edition=full","pubTime":"2025-05-14 23:05","pubTimestamp":1747235156,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日23时05分，Rapport Therapeutics, Inc.股票出现波动，股价急速跳水5.46%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。其相关个股中，Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Liminatus Pharma Inc C/Wts 30/04/2030 涨幅较大，Nucana Plc、Polyrizon Ltd.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为3680.88%、3494.64%、1525.38%，振幅较大的相关个股有Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Onconetix, Inc.，振幅分别为330.31%、201.95%、135.53%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514230556aa2c8eab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514230556aa2c8eab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","RAPP","LENZ","BK4139"],"gpt_icon":0},{"id":"2534151873","title":"Rapport Therapeutics, Inc.盘中异动 股价大涨5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534151873","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534151873?lang=zh_cn&edition=full","pubTime":"2025-05-09 00:39","pubTimestamp":1746722366,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日00时39分，Rapport Therapeutics, Inc.股票出现波动，股价大幅上涨5.48%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.16%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050900392697536e5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050900392697536e5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPP","BK4139","BK4007","LENZ","BK4539"],"gpt_icon":0},{"id":"2533522036","title":"Rapport Therapeutics, Inc.盘中异动 股价大跌5.10%报10.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533522036","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533522036?lang=zh_cn&edition=full","pubTime":"2025-05-07 00:43","pubTimestamp":1746549797,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日00时43分，Rapport Therapeutics, Inc.股票出现波动，股价快速下挫5.10%。截至发稿，该股报10.42美元/股，成交量5.339万股，换手率0.15%，振幅6.50%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为5.17%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050700431794ee31c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050700431794ee31c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPP","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2532767844","title":"Rapport Therapeutics, Inc.盘中异动 大幅上涨7.32%报12.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532767844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532767844?lang=zh_cn&edition=full","pubTime":"2025-05-02 21:33","pubTimestamp":1746192814,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日21时33分，Rapport Therapeutics, Inc.股票出现异动，股价急速上涨7.32%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.45%。其相关个股中，Polyrizon Ltd.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Adaptive Biotechnologies Corporation涨幅较大，Pmgc Holdings Inc.、Polyrizon Ltd.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为206.19%、155.87%、60.03%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Polyrizon Ltd.、Adaptive Biotechnologies Corporation，振幅分别为67.34%、37.45%、18.34%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502213335974d6531&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502213335974d6531&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","RAPP","BK4007"],"gpt_icon":0},{"id":"2532619330","title":"Rapport Therapeutics, Inc.盘中异动 股价大涨5.20%报11.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532619330","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532619330?lang=zh_cn&edition=full","pubTime":"2025-05-01 01:53","pubTimestamp":1746035610,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日01时53分，Rapport Therapeutics, Inc.股票出现波动，股价快速上涨5.20%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.40%。其相关个股中，Regulus Therapeutics Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Abeona Therapeutics Inc.涨幅较大，Purple Biotech Ltd、Processa Pharmaceuticals, Inc.、Regulus Therapeutics Inc.较为活跃，换手率分别为163.79%、37.06%、35.99%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Abeona Therapeutics Inc.、Osr Holdings Inc C/Wts 09/02/2028 ，振幅分别为64.00%、37.52%、34.25%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501015330974bd277&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501015330974bd277&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPP","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2530875132","title":"Rapport Therapeutics, Inc.盘中异动 急速上涨7.06%报11.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530875132","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530875132?lang=zh_cn&edition=full","pubTime":"2025-04-28 21:43","pubTimestamp":1745847829,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日21时43分，Rapport Therapeutics, Inc.股票出现波动，股价快速上涨7.06%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。其相关个股中，Galmed Pharmaceuticals Ltd.、Cg Oncology, Inc.、Portage Biotech Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Portage Biotech Inc.、Tharimmune, Inc.较为活跃，换手率分别为1601.08%、344.16%、66.30%，振幅较大的相关个股有Galmed Pharmaceuticals Ltd.、Protara Therapeutics, Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为27.39%、22.69%、22.50%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428214349a46a91b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428214349a46a91b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","RAPP","BK4139"],"gpt_icon":0},{"id":"2530139163","title":"Rapport Therapeutics, Inc.盘中异动 股价大跌5.41%报10.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530139163","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530139163?lang=zh_cn&edition=full","pubTime":"2025-04-26 01:39","pubTimestamp":1745602790,"startTime":"0","endTime":"0","summary":"北京时间2025年04月26日01时39分，Rapport Therapeutics, Inc.股票出现异动，股价大幅下跌5.41%。截至发稿，该股报10.50美元/股，成交量2.4875万股，换手率0.07%，振幅6.67%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426013950974552ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426013950974552ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","RAPP"],"gpt_icon":0},{"id":"2530966293","title":"Rapport Therapeutics, Inc.盘中异动 下午盘大幅下挫5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530966293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530966293?lang=zh_cn&edition=full","pubTime":"2025-04-25 02:10","pubTimestamp":1745518244,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日02时10分，Rapport Therapeutics, Inc.股票出现异动，股价大幅下跌5.01%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425021045a465b760&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425021045a465b760&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPP","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2529878175","title":"Rapport Therapeutics, Inc.盘中异动 股价大涨6.17%报11.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529878175","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529878175?lang=zh_cn&edition=full","pubTime":"2025-04-22 21:50","pubTimestamp":1745329813,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日21时50分，Rapport Therapeutics, Inc.股票出现波动，股价急速拉升6.17%。截至发稿，该股报11.02美元/股，成交量3840股，换手率0.01%，振幅4.34%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.32%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422215013a6c3df4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422215013a6c3df4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPP","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2527273425","title":"Rapport Therapeutics, Inc.盘中异动 下午盘急速下跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527273425","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527273425?lang=zh_cn&edition=full","pubTime":"2025-04-16 01:30","pubTimestamp":1744738231,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日01时30分，Rapport Therapeutics, Inc.股票出现波动，股价快速下跌5.18%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。其相关个股中，Mural Oncology Plc、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Mural Oncology Plc、Dogwood Therapeutics, Inc.、Metavia Inc.较为活跃，换手率分别为1396.53%、965.04%、253.86%，振幅较大的相关个股有Skye Bioscience, Inc.、Mural Oncology Plc、Dogwood Therapeutics, Inc.，振幅分别为171.53%、97.08%、91.33%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041601303194d65941&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041601303194d65941&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","RAPP","LENZ"],"gpt_icon":0},{"id":"2527136271","title":"Rapport Therapeutics, Inc.盘中异动 快速上涨5.51%报9.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527136271","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527136271?lang=zh_cn&edition=full","pubTime":"2025-04-15 00:44","pubTimestamp":1744649074,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日00时44分，Rapport Therapeutics, Inc.股票出现异动，股价快速上涨5.51%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.02%。其相关个股中，Third Harmonic Bio, Inc.、Theratechnologies Inc.、Metsera, Inc.涨幅较大，Processa Pharmaceuticals, Inc.、Artelo Biosciences, Inc.、Aditxt, Inc.较为活跃，换手率分别为709.10%、650.15%、330.08%，振幅较大的相关个股有Processa Pharmaceuticals, Inc.、Artelo Biosciences, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为72.35%、48.91%、45.11%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415004434a458b422&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415004434a458b422&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","RAPP","LENZ"],"gpt_icon":0},{"id":"2526113276","title":"Rapport Therapeutics, Inc.盘中异动 快速上涨5.64%报9.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526113276","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526113276?lang=zh_cn&edition=full","pubTime":"2025-04-12 01:49","pubTimestamp":1744393759,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日01时49分，Rapport Therapeutics, Inc.股票出现波动，股价快速拉升5.64%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.79%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。消息层面，截至01时49分，《Rapport Therapeutics获摩根大通证券公司首次覆盖，给予优于大市评级, 目标价28.00美元。》资讯为影响Rapport Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412014919aa2c6d28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412014919aa2c6d28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","RAPP"],"gpt_icon":0},{"id":"1126656451","title":"Rapport Therapeutics 2024财年第四季度每股亏损$(0.57)，优于预期$(0.62)，年末现金、现金等价物和短期投资达3.053亿美元，预计可支持运营至2026年底","url":"https://stock-news.laohu8.com/highlight/detail?id=1126656451","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126656451?lang=zh_cn&edition=full","pubTime":"2025-03-11 19:43","pubTimestamp":1741693381,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics 报告季度每股亏损$，优于分析师预期的$，超出8.06%。与去年同期每股亏损$相比，这是一个92.88%的增长。以上内容来自Benzinga Earnings专栏，原文如下：Rapport $Therapeutics$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 8.06 percent. This is a 92.88 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPP","LENZ"],"gpt_icon":0},{"id":"2518274695","title":"Rapport Therapeutics, Inc.盘中异动 股价大跌5.24%报8.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518274695","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518274695?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:00","pubTimestamp":1741615239,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时00分，Rapport Therapeutics, Inc.股票出现波动，股价急速下跌5.24%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为3087.26%、661.78%、287.22%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Impact Biomedical, Inc.，振幅分别为41.36%、40.24%、28.59%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220039abf3078d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220039abf3078d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPP","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2517163165","title":"Rapport Therapeutics, Inc.盘中异动 快速跳水5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517163165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517163165?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:31","pubTimestamp":1741271504,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时31分，Rapport Therapeutics, Inc.股票出现波动，股价快速下挫5.54%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.63%。其相关个股中，Plus Therapeutics, Inc.、Exicure, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为946.46%、104.14%、48.84%，振幅较大的相关个股有Plus Therapeutics, Inc.、Entero Therapeutics Inc.、Astria Therapeutics, Inc.，振幅分别为24.20%、13.05%、11.88%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223145abeb7784&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223145abeb7784&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPP","LENZ","BK4139","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.rapportrx.com","stockEarnings":[{"period":"1week","weight":0.2774},{"period":"1month","weight":0.1687},{"period":"3month","weight":0.6609},{"period":"6month","weight":0.0385},{"period":"1year","weight":-0.3549},{"period":"ytd","weight":-0.133}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":0.0377},{"period":"3month","weight":0.1721},{"period":"6month","weight":0.0781},{"period":"1year","weight":0.1149},{"period":"ytd","weight":0.0678}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Rapport Therapeutics, Inc.于2022年2月根据特拉华州法律注册成立，名称为Precision Neuroscience NewCo, Inc.，并于2022年10月更名为Rapport Therapeutics, Inc.。该公司是一家临床阶段的生物制药公司，专注于通过发现和开发用于中枢神经系统（“CNS”）疾病患者的转化小分子药物，成为精确神经科学的领导者。","exchange":"NASDAQ","name":"Rapport Therapeutics, Inc.","nameEN":"Rapport Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Rapport Therapeutics, Inc.(RAPP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Rapport Therapeutics, Inc.(RAPP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Rapport Therapeutics, Inc.,RAPP,Rapport Therapeutics, Inc.股票,Rapport Therapeutics, Inc.股票老虎,Rapport Therapeutics, Inc.股票老虎国际,Rapport Therapeutics, Inc.行情,Rapport Therapeutics, Inc.股票行情,Rapport Therapeutics, Inc.股价,Rapport Therapeutics, Inc.股市,Rapport Therapeutics, Inc.股票价格,Rapport Therapeutics, Inc.股票交易,Rapport Therapeutics, Inc.股票购买,Rapport Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Rapport Therapeutics, Inc.(RAPP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Rapport Therapeutics, Inc.(RAPP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}